106 related articles for article (PubMed ID: 9017583)
21. Risk of recurrence in patients with surgically resected stage I non-small cell lung carcinoma: histopathologic and immunohistochemical analysis.
Poleri C; Morero JL; Nieva B; Vázquez MF; Rodríguez C; de Titto E; Rosenberg M
Chest; 2003 Jun; 123(6):1858-67. PubMed ID: 12796161
[TBL] [Abstract][Full Text] [Related]
22. 'Tumour volume' as a predictor of survival after resection of non-small-cell lung cancer (NSCLC).
Jefferson MF; Pendleton N; Faragher EB; Dixon GR; Myskow MW; Horan MA
Br J Cancer; 1996 Aug; 74(3):456-9. PubMed ID: 8695364
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of the mammalian target of rapamycin: a novel biomarker for poor survival in resected early stage non-small cell lung cancer.
Dhillon T; Mauri FA; Bellezza G; Cagini L; Barbareschi M; North BV; Seckl MJ
J Thorac Oncol; 2010 Mar; 5(3):314-9. PubMed ID: 20093977
[TBL] [Abstract][Full Text] [Related]
24. High coexpression of both EGFR and IGF1R correlates with poor patient prognosis in resected non-small-cell lung cancer.
Gately K; Forde L; Cuffe S; Cummins R; Kay EW; Feuerhake F; O'Byrne KJ
Clin Lung Cancer; 2014 Jan; 15(1):58-66. PubMed ID: 24210543
[TBL] [Abstract][Full Text] [Related]
25. Fas expression in non-small cell lung cancer: its prognostic effect in completely resected stage III patients.
Uramoto H; Osaki T; Inoue M; Taga S; Takenoyama M; Hanagiri T; Yoshino I; Nakanishi R; Ichiyoshi Y; Yasumoto K
Eur J Cancer; 1999 Oct; 35(10):1462-5. PubMed ID: 10673978
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of volume-based 18F-FDG PET/CT parameter in patients with surgically resected non-small cell lung cancer. Comparison with immunohistochemical biomarkers.
Lee JY; Choi JY; Heo JH; Han J; Jang SJ; Kim K; Kim J; Shim YM; Kim BT
Nuklearmedizin; 2016; 55(1):7-14. PubMed ID: 26875430
[TBL] [Abstract][Full Text] [Related]
27. The prognostic effect of single and multiple cancer-related somatic mutations in resected non-small-cell lung cancer.
Jao K; Tomasini P; Kamel-Reid S; Korpanty GJ; Mascaux C; Sakashita S; Labbé C; Leighl NB; Liu G; Feld R; Bradbury PA; Hwang DM; Pintilie M; Tsao MS; Shepherd FA
Lung Cancer; 2018 Sep; 123():22-29. PubMed ID: 30089591
[TBL] [Abstract][Full Text] [Related]
28. The relationship of quantitative epidermal growth factor receptor expression in non-small cell lung cancer to long term survival.
Veale D; Kerr N; Gibson GJ; Kelly PJ; Harris AL
Br J Cancer; 1993 Jul; 68(1):162-5. PubMed ID: 8391303
[TBL] [Abstract][Full Text] [Related]
29. Clinical implication and prognostic significance of standardised uptake value of primary non-small cell lung cancer on positron emission tomography: analysis of 176 cases.
Al-Sarraf N; Gately K; Lucey J; Aziz R; Doddakula K; Wilson L; McGovern E; Young V
Eur J Cardiothorac Surg; 2008 Oct; 34(4):892-7. PubMed ID: 18722132
[TBL] [Abstract][Full Text] [Related]
30. Do tumours located in the left lower lobe have worse outcomes in lymph node-positive non-small cell lung cancer than tumours in other lobes?
Kudo Y; Saji H; Shimada Y; Nomura M; Usuda J; Kajiwara N; Ohira T; Ikeda N
Eur J Cardiothorac Surg; 2012 Sep; 42(3):414-9. PubMed ID: 22398463
[TBL] [Abstract][Full Text] [Related]
31. Expression of bcl-2 protein in non-small cell lung cancer: correlation with clinicopathology and patient survival.
Laudanski J; Chyczewski L; Niklińska WE; Kretowska M; Furman M; Sawicki B; Nikliński J
Neoplasma; 1999; 46(1):25-30. PubMed ID: 10355530
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of S100A13 protein is associated with tumor angiogenesis and poor survival in patients with early-stage non-small cell lung cancer.
Miao S; Qiu T; Zhao Y; Wang H; Sun X; Wang Y; Xuan Y; Qin Y; Jiao W
Thorac Cancer; 2018 Sep; 9(9):1136-1144. PubMed ID: 30047626
[TBL] [Abstract][Full Text] [Related]
33. Altered retinoblastoma protein expression in nonsmall cell lung cancer: its synergistic effects with altered ras and p53 protein status on prognosis.
Dosaka-Akita H; Hu SX; Fujino M; Harada M; Kinoshita I; Xu HJ; Kuzumaki N; Kawakami Y; Benedict WF
Cancer; 1997 Apr; 79(7):1329-37. PubMed ID: 9083154
[TBL] [Abstract][Full Text] [Related]
34. Identification of subsets of patients with favorable prognosis after recurrence in completely resected non-small cell lung cancer.
Sonobe M; Yamada T; Sato M; Menju T; Aoyama A; Sato T; Chen F; Omasa M; Bando T; Date H
Ann Surg Oncol; 2014 Aug; 21(8):2546-54. PubMed ID: 24633668
[TBL] [Abstract][Full Text] [Related]
35. Association of intra-tumoral tumour-infiltrating lymphocytes and neutrophil-to-lymphocyte ratio is an independent prognostic factor in non-small cell lung cancer.
Dirican N; Karakaya YA; Gunes S; Daloglu FT; Dirican A
Clin Respir J; 2017 Nov; 11(6):789-796. PubMed ID: 26619201
[TBL] [Abstract][Full Text] [Related]
36. Neuroendocrine differentiation as a prognostic factor in non-small cell lung cancer.
Carles J; Rosell R; Ariza A; Pellicer I; Sanchez JJ; Fernandez-Vasalo G; Abad A; Barnadas A
Lung Cancer; 1993 Dec; 10(3-4):209-19. PubMed ID: 7521264
[TBL] [Abstract][Full Text] [Related]
37. Immunoreactivity for thyroid transcription factor-1 in stage I non-small cell carcinomas of the lung.
Pelosi G; Fraggetta F; Pasini F; Maisonneuve P; Sonzogni A; Iannucci A; Terzi A; Bresaola E; Valduga F; Lupo C; Viale G
Am J Surg Pathol; 2001 Mar; 25(3):363-72. PubMed ID: 11224607
[TBL] [Abstract][Full Text] [Related]
38. High expression of CHRNA1 is associated with reduced survival in early stage lung adenocarcinoma after complete resection.
Chang PM; Yeh YC; Chen TC; Wu YC; Lu PJ; Cheng HC; Lu HJ; Chen MH; Chou TY; Huang CY
Ann Surg Oncol; 2013 Oct; 20(11):3648-54. PubMed ID: 23775407
[TBL] [Abstract][Full Text] [Related]
39. LRH1 as a promising prognostic biomarker and predictor of metastasis in patients with non-small cell lung cancer.
Liu Y; Xing Y; Wang H; Yan S; Wang X; Cai L
Thorac Cancer; 2018 Dec; 9(12):1725-1732. PubMed ID: 30273983
[TBL] [Abstract][Full Text] [Related]
40. Keratin 34betaE12/keratin7 expression is a prognostic factor of cancer-specific and overall survival in patients with early stage non-small cell lung cancer.
Pøhl M; Olsen KE; Holst R; Donnem T; Busund LT; Bremnes RM; Al-Saad S; Andersen S; Richardsen E; Ditzel HJ; Hansen O
Acta Oncol; 2016; 55(2):167-77. PubMed ID: 26057535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
